2021 Nov | Board changes announced
2021 Sep | Opal Update and EOFY information
2021 Jul | Biotech Precinct Progress and Withdrawal of Capital Raising
2021 Jun | Formulytica Files New International Patent
2021 Jun | Opal Biosciences Leads Proposal for Biotech Precinct
2021 Jun | Opal Extension of Capital Raise
2021 Jun | Formulytica and Biointelect announce Strategic Partnership
2021 Jun | Growth of Formulytica client base
2021 May| Opal acquisition of Formulytica – Capital raising
2021 May| Opal Biosciences 2021 Information Memorandum
2021 May | Opal’s acquisition of specialist formulation company Formulytica
2019 Nov | AGM 2019 Managing Director presentation
2019 Nov | AGM 2019 Chairman’s Address
2019 Sep | Opal option exercise fuels development plan
2019 Aug | Opal partners in new ARC Research Hub
2019 Mar | Opal Releases Half Year Results Announcement – 31 Dec 2018
2019 Mar | Opal Half-year Financial Report – 31 Dec 2018
2018 Opal Joins Global Antimicrobial Challenge
2018 Opal AGM CEO Presentation
2018 Opal AGM Results of Meeting
2018 Opal AGM Chairman’s Address
2018 Opal Biosciences 2018 Annual Report
2018 Opal Biosciences Notice of Meeting and Proxy Form
2018 August | Opal New Board Addition
2018 July | Opal Information Memorandum Announcement
2018 July | Opal Information Memorandum Document
2018 July | Opal July Presentation
2018 May | BioDiem receives Innovation Connections grant for Opal work
2018 Apr | Half-year Financial Report – 31 Dec 2017
2018 | Completion of Placement and Board change